PMID- 23631499 OWN - NLM STAT- MEDLINE DCOM- 20131212 LR - 20130516 IS - 1557-7600 (Electronic) IS - 1096-620X (Linking) VI - 16 IP - 5 DP - 2013 May TI - Possible therapeutic uses of Salvia triloba and Piper nigrum in Alzheimer's disease-induced rats. PG - 437-46 LID - 10.1089/jmf.2012.0165 [doi] AB - This study aimed to investigate the role of Salvia triloba L. and Piper nigrum extracts in ameliorating neuroinflammatory insults characteristic of Alzheimer's disease (AD) in an experimentally induced rat model. Adult male Sprague-Dawley rats were classified into Group 1 (n=10): normal healthy animals serving as the negative control group; Group 2 (n=60): the AD-induced group. After AD induction, animals in the AD-induced group were divided randomly and equally into 6 subgroups. The first subgroup served as AD control; the second one, which served as positive control, was treated orally with the conventional therapy for AD (rivastigmine) at a dose of 0.3 mg/kg body weight (b.w.) daily for 3 months. The third and fourth subgroups were, respectively, treated orally with the S. triloba extract at a dose of 750 and 375 mg/kg b.w. daily for 3 months. The fifth and sixth subgroups were, respectively, treated orally with the P. nigrum extract at a dose of 187.5 and 93.75 mg/kg b.w. daily for 3 months. Levels of brain acetylcholine (Ach), serum and brain acetylcholinesterase (AchE) activity, C-reactive protein (CRP), total nuclear factor kappa-B (NF-kappaB), and monocyte chemoattractant protein-1 (MCP-1) were estimated. The results showed that administration of AlCl3 resulted in a significant elevation in the levels of AchE activity, CRP, NF-kappaB, and MCP-1 accompanied with a significant depletion in the Ach level. Treatment of AD rats with each of the selected medicinal plant extracts caused marked improvement in the measured biochemical parameters. In conclusion, S. triloba and P. nigrum methanolic extracts have potent anti-inflammatory effects against neuroinflammation characterizing AD. FAU - Ahmed, Hanaa H AU - Ahmed HH AD - Hormones Department, National Research Center, Cairo 12622, Egypt. hanaaomr@yahoo.com FAU - Salem, Ahmed M AU - Salem AM FAU - Sabry, Gilane M AU - Sabry GM FAU - Husein, Ahmed A AU - Husein AA FAU - Kotob, Soheir E AU - Kotob SE LA - eng PT - Journal Article DEP - 20130430 PL - United States TA - J Med Food JT - Journal of medicinal food JID - 9812512 RN - 0 (Chemokine CCL2) RN - 0 (NF-kappa B) RN - 0 (Plant Extracts) RN - 9007-41-4 (C-Reactive Protein) SB - IM MH - Alzheimer Disease/*drug therapy/genetics/immunology MH - Animals MH - C-Reactive Protein/genetics/immunology MH - Chemokine CCL2/genetics/immunology MH - Humans MH - Male MH - NF-kappa B/genetics/immunology MH - Piper nigrum/*chemistry MH - Plant Extracts/*administration & dosage MH - Rats MH - Rats, Sprague-Dawley MH - Salvia/*chemistry EDAT- 2013/05/02 06:00 MHDA- 2013/12/18 06:00 CRDT- 2013/05/02 06:00 PHST- 2013/05/02 06:00 [entrez] PHST- 2013/05/02 06:00 [pubmed] PHST- 2013/12/18 06:00 [medline] AID - 10.1089/jmf.2012.0165 [doi] PST - ppublish SO - J Med Food. 2013 May;16(5):437-46. doi: 10.1089/jmf.2012.0165. Epub 2013 Apr 30.